Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
- Candice L Bizzaro 1,2,3, Camila A Bach 1,2,4,5, Ricardo A Santos 1,2, Cecilia E Verrillo 1,2, Nicole M Naranjo 1,2, Ishan Chaudhari 1,2, Francis J Picone 2, Waleed Iqbal 6, Ada G Blidner 4, Gabriel A Rabinovich 4,5, Alessandro Fatatis 6,7, Justine Jacobi 8, David W Goodrich 8, Kevin K Zarrabi 9, Wm Kevin Kelly 9, Matthew J Schiewer 2,3, Lucia R Languino 1,2
- Candice L Bizzaro 1,2,3, Camila A Bach 1,2,4,5, Ricardo A Santos 1,2
- 1Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 2Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 3Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 4Laboratory of Glycomedicine, Institute of Biology and Experimental Medicine, National Council of Scientific and Technical Investigations, Buenos Aires, Argentina.
- 5Faculty of Exact and Natural Sciences, University of Buenos Aires, Argentina.
- 6Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
- 7Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 8Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- 9Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
- 0Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, Pennsylvania.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Androgen deprivation increases STEAP1 and STEAP2 in prostate cancer cells. STEAP1 is selectively packaged into extracellular vesicles, regardless of androgen receptor status, offering potential therapeutic insights.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Six-transmembrane epithelial antigen of the prostate (STEAP) metalloreductases (STEAP1, STEAP2) are therapeutic targets in advanced prostate cancer.
- STEAP expression is linked to androgen receptor (AR) signaling, but regulatory mechanisms and functions in prostate cancer progression are unclear.
Purpose Of The Study
- To investigate the influence of androgen modulation and AR inhibition on STEAP family member expression in prostate cancer cells.
- To examine STEAP1 and STEAP2 expression in small extracellular vesicles (sEVs) derived from prostate cancer cells and in circulation.
Main Methods
- In vitro androgen modulation and AR inhibition experiments on prostate cancer cell lines.
- Analysis of STEAP family member transcript levels in response to androgen deprivation.
- Evaluation of STEAP1 and STEAP2 expression in cell-derived and circulating sEVs.
- Ex vivo analysis of circulating sEVs from genetically engineered mouse models of prostate cancer.
Main Results
- Androgen deprivation elevated STEAP1 and STEAP2 transcript levels, while reducing STEAP4, mirroring KLK3 expression.
- STEAP1, but not STEAP2, was upregulated in sEVs from both AR-negative and AR-positive cells.
- Selective packaging of STEAP1 into sEVs occurred irrespective of cellular STEAP1 levels and AR status.
- Circulating sEVs in mice with prostate cancer contained STEAP1, independent of prostatic β1 integrin expression.
Conclusions
- STEAP1 exhibits selective packaging into extracellular vesicles in prostate cancer.
- STEAP1 levels in circulating sEVs are independent of AR status and β1 integrin expression.
- Understanding androgen dependence of STEAP1 in tumor cells and sEVs may guide combinatorial therapies.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:36
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:33
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

